Delivery Order SPE2DB22D3501-SPE2DB25FWM15
- Not listed
- The Defense Logistics Agency (DLA) awarded a $6,381.97 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Gen 5) 5S, a diabetes management device. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was placed on July 18, 2025, with an ultimate completion date of July...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,242.98 firm fixed-price contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices, with a period of performance ending on July 1, 2025. This award is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for OMNIPOD 5 DEXCOM G7 PODS (GEN 5) 5S medical devices. The $7,474.94 firm fixed-price award has a completion date of January 28, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,917.12, is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The award has an ultimate completion date of March 26, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This is a $1,655.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5), with a completion date of July 8, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive global pharmaceutical...
- This federal contract award, valued at $7,725.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, with a completion date of July 1, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OMNIPOD 5 DEXCOM G7 Glucose Monitoring System pods. The contract has a firm fixed price of $1,989.20 and a completion date of June 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,231.53 firm fixed-price delivery order is for OMNIPOD 5 DEXCOM G7 Glucose Monitoring Pods, which are medical devices used to manage diabetes. The contract does not have a set-aside designation, indicating it was competitively awarded. The award is associated with AmerisourceBergen's existing Indefinite...
- This federal contract award is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S to the Defense Logistics Agency (DLA), a defense agency. The $56,850.57 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 9, 2025 and was awarded on July 8, 2025. This delivery order is part of a larger $999,999,999.00...
- This is a $12,454.17 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device used for diabetes management, with an ultimate completion date of July 18, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM15Delivery Order
The Defense Logistics Agency awarded a $2,174.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods, with performance in Conshohocken, Pennsylvania and completion by July 21, 2025. This non-set-aside competitive award was issued on July 18, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA Troop Support Medical. The delivery order addresses federal diabetes management and continuous glucose monitoring needs through the supply of specialized medical devices that integrate insulin delivery with real-time glucose monitoring capabilities. This award is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999 through December 2026. As a major pharmaceutical and medical device distributor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's federal contract portfolio demonstrates sustained capability to deliver specialized medical supplies and pharmaceutical products across multiple therapeutic domains to military and veteran healthcare systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/18/25 |